These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3705161)

  • 1. Determination of cyclosporine concentration in bile.
    Scanlon L; Baloh R; Gridelli B; Rao KM; Shaw B; Starzl T; Sanghvi A
    Transplantation; 1986 May; 41(5):657-9. PubMed ID: 3705161
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of cyclosporine and 18 metabolites in blood, bile, and urine by high-performance liquid chromatography.
    Christians U; Schlitt HJ; Bleck JS; Schiebel HM; Kownatzki R; Maurer G; Strohmeyer SS; Schottmann R; Wonigeit K; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):609-13. PubMed ID: 3284110
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation and characterization of cyclosporine metabolites using high-performance liquid chromatography and tandem mass spectrometry.
    Bowers LD; Norman DD; Henion JD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):597-601. PubMed ID: 3284108
    [No Abstract]   [Full Text] [Related]  

  • 4. Excretion of cyclosporine and its metabolites in human bile.
    Burckart GJ; Starzl TE; Venkataramanan R; Hashim H; Wong L; Wang P; Makowka L; Zeevi A; Ptachcinski RJ; Knapp JE
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):46-9. PubMed ID: 3538573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cyclosporine metabolites in human bile, blood, and urine by high-performance liquid chromatography/radioimmunoassay/fast atomic bombardment mass spectroscopy.
    Cheung F; Wong PY; Loo J; Cole EH; Levy GA
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):602-8. PubMed ID: 3284109
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationships of cyclosporine concentrations in serum, whole blood, and bile after renal and hepatic transplantation.
    Vine W; Flye MW; Jatlow P
    Clin Chem; 1986 Oct; 32(10):1828-31. PubMed ID: 3530529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement and disposition of ciclosporin and its metabolites.
    Sewing KF; Christians U; Bleck JS; Schottmann R; Strohmeyer SS
    Bibl Cardiol; 1988; (43):63-72. PubMed ID: 3067724
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine quality control program is a reality.
    Pippenger CE
    Ther Drug Monit; 1985; 7(2):129. PubMed ID: 4024208
    [No Abstract]   [Full Text] [Related]  

  • 9. Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters.
    Kahan BD
    Transplantation; 1985 Nov; 40(5):457-76. PubMed ID: 3904087
    [No Abstract]   [Full Text] [Related]  

  • 10. [A method of determining cyclosporin A and its main metabolite by high performance liquid chromatography. Comparison with the radioimmunologic method].
    Birckel P; Jehl F; Jaegle ML; Minck R
    Therapie; 1988; 43(2):111-6. PubMed ID: 3406929
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation between two radioimmunoassay methods for cyclosporine determination.
    Santiago-Delpin EA; Cervoni WA; Gonzalez ZA; Morales Otero LA
    Transplantation; 1989 Mar; 47(3):569-70. PubMed ID: 2922803
    [No Abstract]   [Full Text] [Related]  

  • 12. Thermospray high-performance liquid chromatography/mass spectrometric determination of cyclosporins.
    Abián J; Stone A; Morrow MG; Creer MH; Fink LM; Lay JO
    Rapid Commun Mass Spectrom; 1992 Nov; 6(11):684-9. PubMed ID: 1467551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine monitoring of cyclosporine in whole blood and in kidney tissue using high performance liquid chromatography.
    Kahn GC; Shaw LM; Kane MD
    J Anal Toxicol; 1986; 10(1):28-34. PubMed ID: 3512913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin. Bioanalytical considerations.
    Schran HF; Robinson WT; Abisch E; Niederberger W
    Prog Allergy; 1986; 38():73-92. PubMed ID: 3523496
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporin assay techniques. Accuracy and reproducibility variables impacting on measurements.
    Holt DW; Johnston A
    Int J Rad Appl Instrum B; 1990; 17(7):733-6. PubMed ID: 2262342
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimized high-performance liquid chromatographic method for the analysis of cyclosporine and three of its metabolites in blood and urine.
    Awni WM; Maloney JA
    J Chromatogr; 1988 Mar; 425(1):233-6. PubMed ID: 3360875
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation of the mechanism of peak broadening observed in the high-performance liquid chromatographic analysis of cyclosporine.
    Bowers LD; Mathews SE
    J Chromatogr; 1985 Sep; 333(1):231-8. PubMed ID: 4066839
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressive properties of cyclosporin metabolites.
    Küllinger B; Steiner G; Woloszczuk W
    Lancet; 1989 Aug; 2(8658):333-4. PubMed ID: 2569136
    [No Abstract]   [Full Text] [Related]  

  • 19. Simple and specific isocratic liquid chromatographic procedure for cyclosporine A determination in whole blood, compared with radioimmunoassay.
    Klíma J; Petrásek R; Kocandrle V
    J Chromatogr; 1987 Jan; 385():357-61. PubMed ID: 3549751
    [No Abstract]   [Full Text] [Related]  

  • 20. Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine.
    Kahan BD; Shaw LM; Holt D; Grevel J; Johnston A
    Clin Chem; 1990 Aug; 36(8 Pt 1):1510-6. PubMed ID: 2201460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.